Plasma dehydroepiandrosterone and androsterone sulphates, androstenedione and urinary androgen metabolites in normal British and Japanese women

Bulbrook, 1976, Plasma oestradiol-17β, oestrone and progesterone and their urinary metabolites in normal British and Japanese women, Europ. J. Cancer, 12, 10.1016/0014-2964(76)90023-2 Bulbrook, 1971, Relation between urinary androgen and corticoid excretion and subsequent breast cancer, Lancet, ii, 395, 10.1016/S0140-6736(71)90113-9 Bulbrook, 1962, Abnormal excretion of urinary steroids by women with early breast cancer, Lancet, ii, 1238, 10.1016/S0140-6736(62)92812-X Wang, 1968, Determination of solvolysed sulphate esters of dehydroepiandrosterone and androsterone in human peripheral plasma by gas-liquid chromatography, J. Endocr., 42, 567, 10.1677/joe.0.0420567 Baird, 1974, The site of secretion of androstenedione in non-pregnant women, J. Endocr., 63, 201, 10.1677/joe.0.0630201 Judd, 1963, Serum androstenedione and testosterone levels during the menstrual cycle, J. clin. Endocrinol., 36, 475, 10.1210/jcem-36-3-475 Lobotsky, 1973, Variations in the concentrations of androstenedione in peripheral plasma of women during the day and during the menstrual cycle, Steroids, 22, 133, 10.1016/0039-128X(73)90078-0 Bulbrook, 1967, The urinary excretion of 11-deoxy-17-oxosteroids and 17-hydroxycorticosteroids by normal Japanese and British women, J. Endocr., 38, 401, 10.1677/joe.0.0380401 Ibayashi, 1961, Determination of adrenocorticotropin in human urine by a benzoic-acid adsorption method, J. clin. Endocrinol., 21, 140, 10.1210/jcem-21-2-140 Koboyashi, 1966, Plasma testosterone and urinary 17-ketosteroids in Japanese and Occidentals, J. clin. Endocrinol, 26, 610, 10.1210/jcem-26-6-610 Sekihara, 1972, A radioimmunoassay for serum dehydroepiandrosterone sulfate, Steroids, 20, 813, 10.1016/0039-128X(72)90059-1 Sekihara, 1973, Plasma dehydroepiandrosterone and dehydroepiandrosterone sulphate, Folia endocr. japonica, 49, 230 Vande Wiele, 1963, Studies on the secretion and interconversion of the androgens, Recent Progr. Hormone Res., 19, 275 MacDonald, 1967, Plasma precursors of estrogens. I. Extent of conversion of plasma delta-4-androstenedione to estrone in normal males and non-pregnant normal, castrate and adrenalectomised females, J. clin. Endocrinol., 27, 1103, 10.1210/jcem-27-8-1103 Baulieu, 1965, An adrenal-secreted “androgen”: Dehydroisoandrosterone sulfate, Rec. Prog. Hormone Res., 21, 411 Wieland, 1965, C19O2 steroids and some of their precursors in blood from normal human adrenals, J. clin. Invest., 44, 159, 10.1172/JCI105122 Baird, 1971, Steroids in blood reflecting ovarian function, 176 Horton, 1966, Androstenedione and testosterone in ovarian venous and peripheral plasma during ovariectomy for breast cancer, J. clin. Endocrinol., 26, 1267, 10.1210/jcem-26-11-1267 Rosenfield, 1969, A competitive protein binding method for the measurement of plasma androstenedione, Steroids, 14, 251, 10.1016/0039-128X(69)90013-0 Horton, 1965, Estimation of androstenedione in human peripheral blood with 35S-thiosemicarbazide, J. clin. Endocrinol., 25, 1237, 10.1210/jcem-25-9-1237 Thorneycroft, 1973, A radioimmunoassay for androstenedione, Steroids, 21, 111, 10.1016/0039-128X(73)90024-X Brennan, 1973, Urinary and plasma androgens in benign breast disease, Lancet, i, 1076, 10.1016/S0140-6736(73)90393-0 Wang, 1975, Urinary and plasma androgens and their relation to familial risk of breast cancer, Europ. J. Cancer, 11, 873, 10.1016/0014-2964(75)90087-0 Pitt, 1974, Androgen metabolites in the urine of average women, nuns and women with regional and metastatic breast cancer, Cancer Forum, 1, 27 Warren, 1940, The relation of “chronic mastitis” to carcinoma of the breast, Surg. Gynecol. Obstet., 71, 257 Anderson, 1974, Genetic study of breast cancer: Identification of a high-risk group, Cancer (Philad), 34, 1090, 10.1002/1097-0142(197410)34:4<1090::AID-CNCR2820340419>3.0.CO;2-J Clemmeson, 1965, Statistical Studies in the Aetiology of Malignant Neoplasma. I. Review and Results, 298 Okamoto, 1971, Urinary excretion of testosterone and epitestosterone and plasma levels of LH and testosterone in the Japanese and Ainu, J. clin. Endocrinol., 32, 673, 10.1210/jcem-32-5-673 Hayward, 1968, Urinary steroids and prognosis in breast cancer, 383 Kumaoka, 1968, Urinary 17-ketosteroid excretion of women with advanced breast cancer, J. clin. Endocrinol., 28, 667, 10.1210/jcem-28-5-667 Wynder, 1968, Current concepts in the aetiology of breast cancer, 32 Kodama, 1975, Hormonal status of breast cancer. II. Abnormal urinary steroid excretion, J. nat. Cancer Inst., 54, 1275, 10.1093/jnci/54.6.1275 Hellman, 1959, Thyroid-androgen inter-relations and the hypocholesteremic effects of androsterone, J. clin. Endocrinol., 19, 936, 10.1210/jcem-19-8-936 Loeser, 1954, A new therapy for prevention of post-operative recurrences in genital and breast cancer, Brit. med. J., ii, 1380, 10.1136/bmj.2.4901.1380 Moosa, 1973, Thyroid status and breast cancer, Ann. Roy. Coll. Surg. (England), 53, 178 Bulbrook, 1964, Urinary 11-deoxy-17-oxosteroids in British and Japanese women with reference to the incidence of breast cancer, Nature (Lond.), 201, 189, 10.1038/201189a0